March 13 (Reuters) - Aralez Pharmaceuticals Inc ARZ.TO
* Aralez reports fourth quarter and full-year 2016 financial results
* Qtrly net revenues increased to $20 million versus $6 million in comparable period of 2015
* Sees 2017 net revenues to be in a range of $80 million to $100 million
* Aralez Pharmaceuticals Inc qtrly loss per share $0.48
* Sees 2017 adjusted EBITDA to be in a range of a loss of $25 million to a loss of $10 million Source text for Eikon: ID:nPn9xCtvLa Further company coverage: ARZ.TO